Literature DB >> 17560112

Antiproliferative, low-calcemic, fluorinated sulfone analogs of 1alpha,25-dihydroxyvitamin D3: chemical synthesis and biological evaluation.

Aimee R Usera1, Patrick M Dolan, Thomas W Kensler, Gary H Posner.   

Abstract

Novel fluorinated sulfone analogs of the hormone 1alpha,25-dihydroxyvitamin D(3) have been designed and synthesized in order to study the biological effects of fluorine incorporation at the terminus of the C,D-ring side chain. Although biologically active 26,27-hexafluorinated 1alpha,25-dihydroxyvitamin D(3) analogs have been synthesized previously, this investigation reports the first successful fluorinated series in which trifluoromethyl sulfone analogs present a favorable biological profile. This study shows that two new analogs featuring incorporation of a synthetically simple single trifluoromethyl sulfone group have significantly increased antiproliferative activity while causing desirably low in vivo calciuria relative to that of calcitriol. Incorporation of additional fluorines, as in a perfluorobutyl analog, results in a loss of antiproliferative activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560112      PMCID: PMC2586064          DOI: 10.1016/j.bmc.2007.05.051

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.

Authors:  M Inaba; S Okuno; Y Nishizawa; K Yukioka; S Otani; I Matsui-Yuasa; S Morisawa; H F DeLuca; H Morii
Journal:  Arch Biochem Biophys       Date:  1987-11-01       Impact factor: 4.013

Review 2.  Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor.

Authors:  Sachiko Yamada; Masato Shimizu; Keiko Yamamoto
Journal:  Med Res Rev       Date:  2003-01       Impact factor: 12.944

3.  Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.

Authors:  G H Posner; Q Wang; G Han; J K Lee; K Crawford; S Zand; H Brem; S Peleg; P Dolan; T W Kensler
Journal:  J Med Chem       Date:  1999-09-09       Impact factor: 7.446

4.  Vitamin D and cancer.

Authors:  Rajendra G. Mehta; Rajeshwari R. Mehta
Journal:  J Nutr Biochem       Date:  2002-05       Impact factor: 6.048

5.  Conceptually new 20-epi-22-oxa sulfone analogues of the hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and biological evaluation.

Authors:  G H Posner; K Crawford; M L Siu-Caldera; G S Reddy; S F Sarabia; D Feldman; E van Etten; C Mathieu; L Gennaro; P Vouros; S Peleg; P M Dolan; T W Kensler
Journal:  J Med Chem       Date:  2000-09-21       Impact factor: 7.446

6.  Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro.

Authors:  P H Stern; T Mavreas; Y Tanaka; H F DeLuca; N Ikekawa; Y Kobayashi
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

7.  A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.

Authors:  R Munker; T Kobayashi; E Elstner; A W Norman; M Uskokovic; W Zhang; M Andreeff; H P Koeffler
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

8.  New vitamin D3 derivatives with unexpected antiproliferative activity: 1-(hydroxymethyl)-25-hydroxyvitamin D3 homologs.

Authors:  G H Posner; T D Nelson; K Z Guyton; T W Kensler
Journal:  J Med Chem       Date:  1992-08-21       Impact factor: 7.446

  8 in total
  1 in total

1.  'Novel alkyl side chain sulfone 1alpha,25-dihydroxyvitamin D3 analogs: a comparison of in vitro antiproliferative activities and in vivo calcemic activities'.

Authors:  Aimee R Usera; Patrick Dolan; Thomas W Kensler; Gary H Posner
Journal:  Bioorg Med Chem       Date:  2009-06-21       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.